I'm Ariel, founder of molCore, a stealth biotech building next-generation programmable biologics. I designed the first two-component protein arrays published in Nature, trained as an HFSP Cross-Disciplinary Fellow in David Baker's lab at UW, and hold a PhD in organic electronics from Technion. I now advise Abiologics on their mirrored-chirality Syntein platform and Decycle Bio on design-build-test pipelines, while pushing de novo protein design and generative AI into drug discovery. Ask me about de novo protein design, generative AI for drug discovery, programmable biologics, and protein materials engineering.
My proposal to design conductive protein materials won Prof. David Baker's trust and an HFSP Cross-Disciplinary Fellowship.
As co-founder and CTO I built a de novo protein design-based drug discovery company, from 2023 to 2025.
My PhD in organic electronics pioneered self-assembling vertical organic field-effect transistors (VOFETs).
I help drive de novo protein engineering with Synteins, fully programmable mirrored-chirality proteins.
I'm Ariel, founder of molCore, a stealth biotech building next-generation programmable biologics. I designed the first two-component protein arrays published in Nature, trained as an HFSP Cross-Disciplinary Fellow in David Baker's lab at UW, and hold a PhD in organic electronics from Technion. I now advise Abiologics on their mirrored-chirality Syntein platform and Decycle Bio on design-build-test pipelines, while pushing de novo protein design and generative AI into drug discovery. Ask me about de novo protein design, generative AI for drug discovery, programmable biologics, and protein materials engineering.
My proposal to design conductive protein materials won Prof. David Baker's trust and an HFSP Cross-Disciplinary Fellowship.
As co-founder and CTO I built a de novo protein design-based drug discovery company, from 2023 to 2025.
My PhD in organic electronics pioneered self-assembling vertical organic field-effect transistors (VOFETs).
I help drive de novo protein engineering with Synteins, fully programmable mirrored-chirality proteins.
By using this service, you agree to the Terms of Service and Privacy Policy.